Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2021 Publisher: Pharmacy Retailing Pty Ltd, t/a Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Auckland, New Zealand Telephone (09) 9185 100 Email: aspen@aspenpharma.co.nz
MODURETIC 50mg/5mg Tablet.
| Pharmaceutical Form |
|---|
|
MODURETIC tablets are plain, peach, diamond shaped, compressed tablets. |
Each tablet contains hydrochlorothiazide 50 mg and amiloride hydrochloride dihydrate 5 mg. For full lists of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Amiloride |
Amiloride has mild diuretic and anti-hypertensive activity. It acts primarily in the distal tubule and does not require aldosterone for its action. Amiloride is a mild natriuretic which does not initiate a concomitant decrease in potassium levels. |
|
| Hydrochlorothiazide |
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
| List of Excipients |
|---|
|
Lactose |
Blister pack, PVC/PVdC/Al – 50 tablets.
Pharmacy Retailing Pty Ltd, t/a Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Auckland, New Zealand
Telephone (09) 9185 100
Email: aspen@aspenpharma.co.nz
Date of first approval: 4 August 2010
| Drug | Countries | |
|---|---|---|
| MODURETIC | Australia, Brazil, Estonia, Mexico, New Zealand, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
